- Home
- CYTK vs ESGR Comparison
CYTK vs ESGR Comparison
Compare CYTK & ESGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- ESGR
- Stock Information
- Founded
- CYTK 1997
- ESGR 2001
- Country
- CYTK United States
- ESGR Bermuda
- Employees
- CYTK N/A
- ESGR N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- ESGR Property-Casualty Insurers
- Sector
- CYTK Health Care
- ESGR Finance
- Exchange
- CYTK Nasdaq
- ESGR Nasdaq
- Market Cap
- CYTK 5.6B
- ESGR 4.7B
- IPO Year
- CYTK 2004
- ESGR N/A
- Fundamental
- Price
- CYTK $39.48
- ESGR $334.01
- Analyst Decision
- CYTK Strong Buy
- ESGR
- Analyst Count
- CYTK 17
- ESGR 0
- Target Price
- CYTK $81.63
- ESGR N/A
- AVG Volume (30 Days)
- CYTK 2.6M
- ESGR 129.2K
- Earning Date
- CYTK 05-07-2025
- ESGR 05-01-2025
- Dividend Yield
- CYTK N/A
- ESGR N/A
- EPS Growth
- CYTK N/A
- ESGR N/A
- EPS
- CYTK N/A
- ESGR 35.90
- Revenue
- CYTK $18,474,000.00
- ESGR $1,205,000,000.00
- Revenue This Year
- CYTK $55.84
- ESGR N/A
- Revenue Next Year
- CYTK $659.85
- ESGR N/A
- P/E Ratio
- CYTK N/A
- ESGR $9.28
- Revenue Growth
- CYTK 145.34
- ESGR 3.35
- 52 Week Low
- CYTK $32.74
- ESGR $276.32
- 52 Week High
- CYTK $68.76
- ESGR $348.48
- Technical
- Relative Strength Index (RSI)
- CYTK 46.41
- ESGR 59.68
- Support Level
- CYTK $37.79
- ESGR $331.05
- Resistance Level
- CYTK $40.22
- ESGR $335.00
- Average True Range (ATR)
- CYTK 3.16
- ESGR 1.95
- MACD
- CYTK 0.25
- ESGR 0.11
- Stochastic Oscillator
- CYTK 61.55
- ESGR 87.84
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About ESGR Enstar Group Limited
Enstar Group Ltd is a (re)insurance group that offers capital release solutions through its network of group companies. It seeks to create value by managing (re)insurance companies and portfolios of (re)insurance and other liability businesses in run-off and striving to generate an attractive risk-adjusted return from its investment portfolio. Its operations are through four reportable segments: Run-off, Assumed Life, Investments, and Legacy Underwriting.